National Institute of Mental Health (NIMH)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Mental Health (NIMH) sits in the top decile of US sponsors by registered trial count (#103 of 15,742 sponsors by registered trial count).
National Institute of Mental Health (NIMH): 343 sponsored US clinical trials, 42 recruiting.
National Institute of Mental Health (NIMH) sponsors 343 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 256 completed. 29 of these trials are in Phase 3-4 (later-stage) and 106 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 21 trials.
Top-decile sponsor footprint
National Institute of Mental Health (NIMH) ranks in the top decile of sponsors by registered trial count (#103 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
256 of 296 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
343 total, page 7 of 7
The Evaluation and Follow-up of Patients With Bipolar Disorder
NCT00001652
Genetics of Obsessive-Compulsive Disorder
NCT00001548
Neuropsychiatric Effects of Interferon-Alpha and Ribavirin
NCT00001547
Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers
NCT00001546
Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
NCT00001545
The Role of Hormones in Postpartum Mood Disorders
NCT00001481
Genetic Aspects of Neurologic and Psychiatric Disorders
NCT00001544
Dynamics of Leptin and Endocrine Function
NCT00001543
Genetic Study of Schizophrenia
NCT00001486
Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder
NCT00001485
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
NCT00001483
Treatment of Mid-Life-Related Mood Disorders
NCT00001487
New Drugs in the Treatment of Mood Disorders
NCT00001482
The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480
Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression
NCT00001479
Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
NCT00001478
The Effects of Reproductive Hormones on Mood and Behavior
NCT00001322
Glucocorticoid Effects on Cellular Cytokine Release
NCT00001415
Bone Mineral Density in Women With Major Depression
NCT00001413
Mapping Personality Traits to Genes
NCT00001414
Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement
NCT00001412
Studies of Frontal Lobe Brain Functioning in Schizophrenia
NCT00001258
PEG-Glucocerebrosidase for the Treatment of Gaucher Disease
NCT00001410
Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
NCT00001359
A Treatment Study for Premenstrual Syndrome (PMS)
NCT00001259
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323
Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders
NCT00004557
Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients
NCT00001320
The Effects of Dextroamphetamine on Brain Function
NCT00004556
Effects of Sex Hormones on Circadian Rhythm in Men and Women
NCT00001285
Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
NCT00001284
Brain Tissue Collection for Neuropathological Studies
NCT00001260
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
NCT00000392
Inpatient Evaluation of Adults With Schizophrenia
NCT00001247
Perimenopause-Related Mood and Behavioral Disorders
NCT00001231
Study of Children at Risk for Disruptive Behavior Disorders
NCT00001233
The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders
NCT00001232
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
NCT00000393
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
NCT00000391
Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00001206
Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
NCT00001198
Neuropsychological Evaluation of Psychiatric and Neurological Patients
NCT00001192
Study of the Psychological Development of Children of Parents With and Without Affective Disorders
NCT00001170
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 61 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the National Institute of Mental Health (NIMH) pipeline
42 recruiting of 343 indexed (12% open); 256 completed (75%).
Phase mix: 29 late (III/IV) vs 106 early (I/II) (early-phase heavy).
Top condition: Healthy (21 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Mental Health (NIMH): open-pipeline peers nationwide
Peers matched on 343 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
National Institute of Mental Health (NIMH) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 343 trials (± recruiting share)
- Children's Oncology Group · 342 trials · 10% recruiting
- Montefiore Medical Center · 345 trials · 19% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Augusta University · 12% recruiting · 106 trials
- University of Iowa · 12% recruiting · 228 trials
- Daiichi Sankyo · 12% recruiting · 236 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this National Institute of Mental Health (NIMH) page
343 registered trials is a research-attention snapshot, not an endorsement of National Institute of Mental Health (NIMH) or any single study.
- 42 of National Institute of Mental Health (NIMH)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Mental Health (NIMH) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Mental Health (NIMH) pipeline card: 343 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.